Found 5 matching trials
A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy
PHASE1This is an open, multi-cohort clinical study. The first phase is a dose esc...
Location
Henan Cancer Hospital
Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)
PHASE2TQB3702 is a selective kinase inhibitor. This is a Phase II clinical study ...
Location
The First Affilliated Hospital of Bengbu Medical University
A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma
PHASE2To evaluate the efficacy and safety of TQB3702 tablets combined with immuno...
Location
Cancer Hospital Chinise Academy of Medical Sciences
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult Subjects
PHASE1This is a phase I, randomized, double-blind, placebo-controlled, dose-escal...
Location
Guangdong provincial people's hospital
Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects
PHASE1This project is an open, dose escalation and expansion phase I clinical stu...
Location
The First Affiliated Hospital of Nanchang University